How to buy Nevro stock (NVRO)

Nevro is a medical devices business based in the US. Nevro shares (NVRO) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $3.59 – a decrease of 14.93% over the previous week. Nevro employs 1,215 staff and has a trailing 12-month revenue of around $419.1 million.

Our top picks for where to buy Nevro stock

Buy Nevro stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Nevro stock price (NYSE: NVRO)

Use our graph to track the performance of NVRO stocks over time.

Nevro shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$3.59
52-week range	$3.56 - $22.53
50-day moving average more info button	$4.73
200-day moving average more info button	$8.19
Wall St. target price	$6.13
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-1.87

Is it a good time to buy Nevro stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Nevro price performance over time

Historical closes compared with the close of $3.74 from 2024-12-18

1 week (2024-12-13)	-8.11%
1 month (2024-11-20)	-11.58%
3 months (2024-09-20)	-36.07%
6 months (2024-06-20)	-56.46%

1 year (2023-12-20)	-82.24%
2 years (2022-12-20)	-90.79%
3 years (2021-12-20)	82.54
5 years (2019-12-20)	114.32

Nevro financials

Revenue TTM	$419.1 million
Gross profit TTM	$276.4 million
Return on assets TTM	-9.02%
Return on equity TTM	-24.78%
Profit margin	-16.54%
Book value	$7.31
Market Capitalization more info button	$140.1 million

TTM: trailing 12 months

Nevro share dividends

We're not expecting Nevro to pay a dividend over the next 12 months.

Have Nevro's shares ever split?

Nevro's shares were split on a 1:24 basis on 5 November 2014 . So if you had owned 24 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Nevro shares – just the quantity. However, indirectly, the new 2300% higher share price could have impacted the market appetite for Nevro shares which in turn could have impacted Nevro's share price.

Nevro share price volatility

Over the last 12 months, Nevro's shares have ranged in value from as little as $3.56 up to $22.525. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Nevro's is 0.931. This would suggest that Nevro's shares are less volatile than average (for this exchange).

Nevro overview

Nevro Corp. , a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.

Frequently asked questions

What percentage of Nevro is owned by insiders or institutions?
Currently 3.678% of Nevro shares are held by insiders and 103.833% by institutions. How many people work for Nevro?
Latest data suggests 1,215 work at Nevro. When does the fiscal year end for Nevro?
Nevro's fiscal year ends in December. Where is Nevro based?
Nevro's address is: 1800 Bridge Parkway, Redwood City, CA, United States, 94065 What is Nevro's ISIN number?
Nevro's international securities identification number is: US64157F1030 What is Nevro's CUSIP number?
Nevro's Committee on Uniform Securities Identification Procedures number is: 64157F103